International safety notice
General name: Somatic cell gene mutation analysis system (for determining the suitability of anti-cancer drugs) Brand name: Oncomine Dx Target Test Multi CDx System
Japan / PMDA Recalls · JPN · Sep 22, 2021
Key facts
| Regulator | Japan / PMDA Recalls |
|---|---|
| Country | JPN |
| Brand | General name: Somatic cell gene mutation analysis system (for determining the suitability of anti-cancer drugs) Brand name: Oncomine Dx Target Test Multi CDx System |
| Manufacturer | Life Technologies Japan Co., Ltd. |
| Models | S119_2174730, S118_2001074, Z119_2233046, N119_2115949, S120_2318508, K120_2236898, K121_2292376, N121_2402766, P119_2143998, N121_2393105, P119_2143994, K120_2243458 and 300 more |
| Date | Sep 22, 2021 |
| Regulator page | info.pmda.go.jp |
At a glance
- No Recall
- No Field safety notice
- 1–9 Matching device models in FDA data
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About International device safety notices
Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.
Source: National medical device regulators (as listed), compiled by Orca1